Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marina Varga

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Orvosi Hetilap|July 6, 2007
[Hepatitis B and liver transplantation]Imre Fehérvári, Dénes Görög, László Kóbori, et al.
Nutrients|February 13, 2025
Effect of Moderately High-Dose Vitamin D3 Supplementation on Mortality in Patients Hospitalized for COVID-19 InfectionLiza Dalma Sümegi, Marina Varga, Veronika Kadocsa, et al.
Magyar Sebeszet|October 15, 2011
[Incidence of thrombophilia and risk of renal vessel thrombosis in kidney transplant recipients]Eva Toronyi, Zsolt Máthé, Rita Chmel, et al.
Orvosi Hetilap|March 18, 2008
[Cytomegalovirus infection after solid-organ transplantation, its risk factors, direct and indirect effects and prevention strategies]Marina Varga, Adám Remport, Krisztina Czebe, et al.
Orvosi Hetilap|February 3, 2004
[Combined interferon-alfa-2b and ribavirin therapy in patients with recurrent chronic hepatitis c after liver transplantation]Gabriella Lengyel, László Kóbori, Imre Fehérvári, et al.
Transplantation Proceedings|January 10, 2024
Low-Dose vs Standard-Dose Valganciclovir for Cytomegalovirus Prophylaxis After Kidney Transplantation: A Single-Center Retrospective AnalysisKatalin Farkas, Marina Varga, Izabella Dinnyes, et al.
Orvosi Hetilap|May 28, 2013
[Progress of the liver transplantation programme in Hungary]László Kóbori, Dénes Görög, Imre Fehérvári, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 12, 2008
HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patientsMarina Varga, Katalin Rajczy, Gábor Telkes, et al.
Orvosi Hetilap|August 11, 2005
[The demographic, perioperative and mortality characteristics of the Hungarian Liver Transplant Program]Balázs Nemes, Eniko Sárváry, László Kóbori, et al.
European Journal of Gastroenterology & Hepatology|October 20, 2017
Shear-wave elastography for the assessment of liver fibrosis in liver transplant recipients treated for hepatitis C virus recurrenceDavid Korda, Zsuzsanna M Lenard, Zsuzsanna Gerlei, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Orvosi Hetilap|July 6, 2007
[Hepatitis B and liver transplantation]Imre Fehérvári, Dénes Görög, László Kóbori, et al.
Nutrients|February 13, 2025
Effect of Moderately High-Dose Vitamin D3 Supplementation on Mortality in Patients Hospitalized for COVID-19 InfectionLiza Dalma Sümegi, Marina Varga, Veronika Kadocsa, et al.
Magyar Sebeszet|October 15, 2011
[Incidence of thrombophilia and risk of renal vessel thrombosis in kidney transplant recipients]Eva Toronyi, Zsolt Máthé, Rita Chmel, et al.
Orvosi Hetilap|March 18, 2008
[Cytomegalovirus infection after solid-organ transplantation, its risk factors, direct and indirect effects and prevention strategies]Marina Varga, Adám Remport, Krisztina Czebe, et al.
Orvosi Hetilap|February 3, 2004
[Combined interferon-alfa-2b and ribavirin therapy in patients with recurrent chronic hepatitis c after liver transplantation]Gabriella Lengyel, László Kóbori, Imre Fehérvári, et al.
Transplantation Proceedings|January 10, 2024
Low-Dose vs Standard-Dose Valganciclovir for Cytomegalovirus Prophylaxis After Kidney Transplantation: A Single-Center Retrospective AnalysisKatalin Farkas, Marina Varga, Izabella Dinnyes, et al.
Orvosi Hetilap|May 28, 2013
[Progress of the liver transplantation programme in Hungary]László Kóbori, Dénes Görög, Imre Fehérvári, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 12, 2008
HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patientsMarina Varga, Katalin Rajczy, Gábor Telkes, et al.
Orvosi Hetilap|August 11, 2005
[The demographic, perioperative and mortality characteristics of the Hungarian Liver Transplant Program]Balázs Nemes, Eniko Sárváry, László Kóbori, et al.
European Journal of Gastroenterology & Hepatology|October 20, 2017
Shear-wave elastography for the assessment of liver fibrosis in liver transplant recipients treated for hepatitis C virus recurrenceDavid Korda, Zsuzsanna M Lenard, Zsuzsanna Gerlei, et al.
Pageof 3